Shares of Glenmark Life Sciences on Friday made a lacklustre debut with its shares getting listed at ₹751.20, a 4 per cent premium over issue price of ₹720 a share on the bourses.
It opened opened at ₹750 on the NSE and at ₹751.20 on the BSE. However, after hitting a high of ₹605, the stock is currently ruling at ₹598.70, up about 7 per cent.
Glenmark Life Sciences' initial public offering saw a robust response from all categories of investors, as the issue was subscribed by 44.17 times.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.